Inferior Vena Cava Atresia: Characterisation of Risk Factors, Treatment, and Outcomes

  • Tarub S. MabudEmail author
  • Anna M. Sailer
  • Joshua K. Y. Swee
  • Mallika Tamboli
  • Victoria A. Arendt
  • Gyeong-Sik Jeon
  • Xiao An
  • David M. Cohn
  • William T. Kuo
  • Lawrence V. Hofmann
Clinical Investigation Venous Interventions
Part of the following topical collections:
  1. Venous Interventions



To characterise (1) the risk factors associated with inferior vena cava (IVC) atresia, (2) the radiographic and clinical presentations of deep vein thrombosis (DVT) in patients with IVC atresia, and (3) the treatment and outcome of DVT in patients with IVC atresia.


The electronic medical record was systematically reviewed for thrombotic risk factors in patients who presented with lower-extremity DVT (n = 409) at a single centre between 1996 and 2017. Patients with IVC atresia were identified based on imaging and chart review. Differences in demographics and thrombotic risk factors between patients with and without IVC atresia were statistically assessed. Extent and chronicity of DVT on imaging, clinical presentation, treatment, and outcomes were evaluated for all patients with IVC atresia.


4.2% of DVT patients (17/409) were found to have IVC atresia; mean age at diagnosis was 25.5 ± 9.4 years. The rate of heritable thrombophilia was significantly higher in patients with IVC atresia compared to patients without IVC atresia (52.9% vs. 17.9%, p < 0.0001). There were bilateral DVT in 70.6% of IVC atresia patients; DVT was chronic in 41.2% and acute on chronic in 58.8%. Pre-intervention Villalta scores were 13.9 ± 9.8 in the left limb and 8.5 ± 7.0 in the right limb. DVT in IVC atresia patients was typically treated with catheter-directed thrombolysis followed by stent placement, achieving complete or partial symptom resolution in 78.6% of cases.


Thrombotic risk factors such as heritable thrombophilia are associated with IVC atresia. IVC atresia patients can experience high burdens of lower-extremity thrombotic disease at a young age which benefit from endovascular treatment.

Level of Evidence

Level 4.


Inferior vena cava atresia Deep vein thrombosis Endovascular intervention Thrombophilia 



This study was funded by the Stanford Medical Scholars Grant, and the Stanford Department of Radiology. The funders had no role in study design, data collection, analysis, or interpretation, decision to publish, or preparation of the manuscript.

Compliance within Ethical Standards

Conflict of interest

L.V.H. is a paid consultant for Cook, Inc. (Bloomington, Indiana) and W.L. Gore & Associates (Flagstaff, Arizona); is a shareholder in Cook, Inc.; owns equity in Confluent Medical (Scottsdale, Arizona), Boston Scientific (Marlborough, Massachusetts), and Medtronic (Minneapolis, Minnesota); and is the founder of, on the board of directors for, and owns equity in Grand Rounds (San Francisco, California). None of the other authors have identified a conflict of interest.

Ethical Approval

This study is approved by the Stanford Institutional Review Board (#33192). For this retrospective study, formal consent is not required.

Informed Consent

For this type of study informed consent is not required.

Consent for Publication

For this type of study consent for publication is not required.


  1. 1.
    Ghandour A, Partovi S, Karuppasamy K, Rajiah P. Congenital anomalies of the IVC-embryological perspective and clinical relevance. Cardiovasc Diagn Ther. 2016;6(6):482–92.CrossRefGoogle Scholar
  2. 2.
    Smillie RP, Shetty M, Boyer AC, Madrazo B, Jafri SZ. Imaging Evaluation of the inferior vena cava. RadioGraphics. 2015;35(2):578–92.CrossRefGoogle Scholar
  3. 3.
    Bass JE, Redwine MD, Kramer LA, Harris JH. Absence of the infrarenal inferior vena cava with preservation of the suprarenal segment as revealed by CT and MR venography. Am J Roentgenol. 1999;172(6):1610–2.CrossRefGoogle Scholar
  4. 4.
    Minniti S, Visentini S, Procacci C. Congenital anomalies of the venae cavae: embryological origin, imaging features and report of three new variants. Eur Radiol. 2002;12(8):2040–55.CrossRefGoogle Scholar
  5. 5.
    Koc Z, Oguzkurt L. Interruption or congenital stenosis of the inferior vena cava: prevalence, imaging, and clinical findings. Eur J Radiol. 2007;62(2):257–66.CrossRefGoogle Scholar
  6. 6.
    Koppisetty S, Smith AG, Dhillon RK. Incidental finding of inferior vena cava atresia presenting with deep venous thrombosis following physical exertion. Case Rep Emerg Med. 2015;2015:1–4.CrossRefGoogle Scholar
  7. 7.
    Harris PA, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRefGoogle Scholar
  8. 8.
    Lowe HJ, Ferris TA, Hernandez PM, Weber SC. STRIDE–an integrated standards-based translational research informatics platform. AMIA Annu Symp Proc AMIA Symp. 2009;2009:391–5.PubMedGoogle Scholar
  9. 9.
    Carpenter JP, et al. Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg. 1993;18(5):734–41.CrossRefGoogle Scholar
  10. 10.
    Baldt MM, et al. Deep venous thrombosis of the lower extremity: efficacy of spiral CT venography compared with conventional venography in diagnosis. Radiology. 1996;200(2):423–8.CrossRefGoogle Scholar
  11. 11.
    Bass JE, Redwine MD, Kramer LA, Huynh PT, Harris JH. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. RadioGraphics. 2000;20(3):639–52.CrossRefGoogle Scholar
  12. 12.
    Vedantham S, et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol. 2009;20(7):S391–408.CrossRefGoogle Scholar
  13. 13.
    Ahmed O, et al. Endovascular stent placement for May-Thurner syndrome in the absence of acute deep vein thrombosis. J Vasc Interv Radiol. 2016;27(2):167–73.CrossRefGoogle Scholar
  14. 14.
    R Core Team (2014). R: a language and environment for statistical computing. R Found Stat Comput Vienna, Austria 2015.
  15. 15.
    Sheley RC, Nyberg DA, Kapur R. Azygous continuation of the interrupted inferior vena cava: a clue to prenatal diagnosis of the cardiosplenic syndromes. J Ultrasound Med. 1995;14(5):381–7.CrossRefGoogle Scholar
  16. 16.
    MacRae JM, Ahmed A, Johnson N, Levin A, Kiaii M. Central vein stenosis: a common problem in patients on hemodialysis. ASAIO J. 2005;51(1):77–81.CrossRefGoogle Scholar
  17. 17.
    Chirinos JA, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. 2005;45(9):1467–71.CrossRefGoogle Scholar
  18. 18.
    Rivard A, et al. Age-dependent impairment of angiogenesis. Circulation. 1999;99(1):111–20.CrossRefGoogle Scholar
  19. 19.
    Anderson RC, Adams P, Burke B. Anomalous inferior vena cava with azygos continuation (infrahepatic interruption of the inferior vena cava). Report of 15 new cases. J Pediatr. 1961;59(3):370–83.CrossRefGoogle Scholar
  20. 20.
    Broholm R, Jørgensen M, Just S, Jensen LP, Bækgaard N. Acute iliofemoral venous thrombosis in patients with atresia of the inferior vena cava can be treated successfully with catheter-directed thrombolysis. J Vasc Interv Radiol. 2011;22(6):801–5.CrossRefGoogle Scholar
  21. 21.
    Ganguli S, et al. Efficacy of lower-extremity venous thrombolysis in the setting of congenital absence or atresia of the inferior vena cava. Cardiovasc Interv Radiol. 2012;35(5):1053–8.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019

Authors and Affiliations

  • Tarub S. Mabud
    • 1
    Email author
  • Anna M. Sailer
    • 1
  • Joshua K. Y. Swee
    • 1
  • Mallika Tamboli
    • 1
  • Victoria A. Arendt
    • 1
  • Gyeong-Sik Jeon
    • 2
  • Xiao An
    • 3
  • David M. Cohn
    • 1
  • William T. Kuo
    • 1
  • Lawrence V. Hofmann
    • 1
  1. 1.Stanford University School of MedicineStanfordUSA
  2. 2.CHA University Bundang Medical CenterSeongnamSouth Korea
  3. 3.Shanghai General HospitalShanghaiChina

Personalised recommendations